The winners of venture case are...
11.12.2014
Two promising high-tech startups deserved the support of the venture kick jury and got awarded with CHF 20’000 each. One measures the concentration of specific analytes in blood, the other develops a new generation of sales forecasting tools.
 The Lucentix Team
|
 |
 Peter Kauf from PrognosiX AG
|
|
Measuring the concentration of specific analytes in blood at the point of care.
Lucentix develops in vitro diagnostics to measure precise concentrations of analytes in single drops of body fluids at the point of care.
Comprehensive Forecasting.
PrognosiX is developping a business intelligence solution for sales forecasting in the food market. They combine historic sales data and external influences like weather into reliable forecasts that are transparently communicated in view of decision support.